Acute monoblastic and monocytic leukemia
Acute monoblastic and monocytic leukemia (AMML) is a subtype of acute myeloid leukemia (AML), a cancer of the blood and bone marrow. This type of leukemia is characterized by a rapid increase in the number of immature white blood cells (monoblasts and monocytes) in the blood and bone marrow.
Etiology[edit | edit source]
The exact cause of AMML is unknown, but it is believed to be a result of genetic mutations. Some researchers suggest that exposure to certain chemicals, radiation, and some drugs may increase the risk of developing this disease. However, more research is needed to confirm these theories.
Symptoms[edit | edit source]
Symptoms of AMML can vary, but often include fatigue, fever, weight loss, and frequent infections due to the decreased number of healthy white blood cells. Other symptoms may include bleeding and bruising easily due to a low number of platelets, and anemia due to a low number of red blood cells.
Diagnosis[edit | edit source]
Diagnosis of AMML is typically made through blood tests and bone marrow biopsy. The presence of a high number of monoblasts and monocytes in the blood or bone marrow is indicative of this disease. Other diagnostic tests may include cytogenetic analysis and immunophenotyping.
Treatment[edit | edit source]
Treatment for AMML typically involves chemotherapy to kill the cancer cells. In some cases, a stem cell transplant may be considered. The choice of treatment depends on a number of factors, including the patient's age, overall health, and the specific characteristics of the leukemia.
Prognosis[edit | edit source]
The prognosis for AMML varies depending on a number of factors, including the patient's age, overall health, and response to treatment. In general, the prognosis is better for younger patients and those who respond well to treatment.
See also[edit | edit source]
 | This oncology article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
